SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (4857)8/11/1998 8:10:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
BBC - GPs flock to impotence course
Tuesday, August 11, 1998 Published at 18:18 GMT 19:18 UK

Viagra has led to a surge in inquiries about impotence treatments

An impotence course for doctors is having no trouble
filling its places as GPs seek help in dealing with a flood
of queries in the wake of Viagra.

The Erectile Dysfunction in Primary Care course, set up
by 14 experts in the field of impotence and reviewed by
over 40 medical professionals, aims to teach health
workers about the new range of impotence treatments on
offer.

These include the little blue wonder drug Viagra,
manufactured by Pfizer, which is being credited with
giving middle-aged men the libido of a 20-year-old.

Despite the fact that US drug authorities are
investigating up to 40 deaths linked to the drug, it is still
being snapped up by Americans.

It is expected to be licensed for sale in Europe in the
autumn, but GPs in the UK say they are already being
inundated with inquiries about the drug, known as
Pfizer's Riser.

One in 10

Nottingham GP Dr Peter Barrett, a council member of
the Institution of Psycho-Sexual Medicine, has reported
inquiries from at least 100 men about Viagra at his
surgery.

Around 10% of British men are thought to suffer from
impotence.

Already 250 GPs have attended the first sessions of the
EDiPC course.

The aim is to teach GPs so that they can pass on their
knowledge to their peers in preparation for the expected
onslaught of inquiries when the new treatments come on
stream.

Popping a pill

Up until now, the main treatments for impotence have
tended to involve uncomfortable remedies, such feeding
tubes up the penis.

But Viagra has heralded a new generation of treatments
which are much easier to take and which have
encouraged men to come forward about their problems.

Pfizer is itself developing a second generation pill and
the Schering Plough organisation has recently applied
for US approval for its impotence drug Vasomax.

British doctors predict that if Viagra were made freely
available on the NHS it could cost as much as œ1bn a
year.

But the Department of Health says the drug will only be
available to those whose impotence has been clinically
diagnosed.

news.bbc.co.uk